NanoDermaTx

Diabetic foot ulcer patients face delayed healing and recurrent wounds, with amputation risks reaching 50% and significant loss of mobility. NanoDermaTx is developing a self-administered, multifunctional smart nanogel that personalizes therapy to wound biology, accelerates healing, and reduces clinic visits.